Developer docs
API playgroundTry for free, no card

Search company profiles

Mycorena

Full company profile

uuid0002aok

Namestring
Mycorena
Legal namestring
Mycorena AB
Websiteurl
mycorena.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Mycorena was a Swedish biotech startup founded in 2017 that developed Promyc, a 100% natural fermented mycoprotein ingredient produced from fungal mycelium through a proprietary fermentation process. The company's core technology combined locally sourced sugars and nutrients with proprietary fungal strains in a high-growth-rate fermentation process, yielding a mycelium root-like structure marketed as having neutral taste, strong nutritional value, and functional structuring properties suitable for meat alternatives, vegan cheese, hybrid meat-mycoprotein products, snacks, and protein-enriched foods. Mycorena operated as a B2B ingredient supplier targeting food manufacturers, offering co-creation services and semi-finished Promyc product, with distribution primarily in Europe and a notable partnership with Swedish retailer ICA Group for mycoprotein nuggets.

Mycorena raised approximately €24 million in a March 2022 Series A — described at the time as Europe's largest Series A for a Nordic alternative protein company — alongside a €1.5 million joint grant with Revo Foods in January 2023 for 3D-printed mycoprotein development. Despite these capital raises, the company encountered financial difficulties when further funding attempts failed and large-scale projects were discontinued, leading to a bankruptcy filing. In August 2024, Naplasol, a member of Belgium-based VEOS Group, acquired Mycorena, assuming ownership of the Promyc brand and mycoprotein technology. Since the acquisition, Promyc has been produced at Naplasol's facility in Bree, Belgium (Kanaal-Noord 1424), with an expanded applications portfolio marketed through a dedicated B2B co-creation channel targeting enterprise food manufacturers. Mycorena no longer operates as an independent entity; the Promyc platform is now a product line within Naplasol/VEOS Group.

Short descriptiontext

Mycorena developed Promyc, a mycelium-based fermented mycoprotein ingredient, supplying European food manufacturers via a B2B co-creation model for vegan meat, cheese, and hybrid products. Founded in Sweden in 2017, the company filed for bankruptcy and was acquired by Naplasol (VEOS Group) in August 2024.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBree, Belgium
HQ citystring
Bree
HQ countrystring
Belgium
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
mycoprotein ingredients, fungal fermentation technology, plant-based protein ingredients, B2B food ingredients, alternative protein supply
Industry2 codes
PRIMARYAFAJAHAE
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYAFAKAGAG
Mycoprotein-Based Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
NAICS code1 code
  • Food Manufacturing311
SIC code2 codes
  • Miscellaneous Food Preparations & Kindred Products2090
  • Food And Kindred Products2000
Product category
Alternative Protein Ingredients
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1B2B Mycoprotein Ingredient Sales
TypeSubscription Recurring
Description

Naplasol (now owning Mycorena's Promyc) operates as an industrial B2B supplier selling mycoprotein ingredients to food manufacturers for use in vegan and hybrid food products.

promyc.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Promyc
Description

Mycoprotein ingredient brand developed by Mycorena, now owned and produced by Naplasol. Used in vegan meat alternatives, hybrid products, cheese alternatives, and various food applications.

promyc.com
Core offering1 text field

Mycorena develops and supplies Promyc®, a 100% natural fermented mycoprotein ingredient produced from fungal mycelium through controlled fermentation. The ingredient is sold as a semi-finished B2B product to food manufacturers, who use it to develop vegan meat alternatives, vegan cheeses, hybrid meat-mycoprotein products, and other protein-enriched foods. Co-creation services support customers in formulating commercial products using Promyc.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Mycorena, now owned by Naplasol (a member of VEOS Group), offers Promyc® as its core mycoprotein ingredient. Promyc® is a 100% natural, fermented mycoprotein produced through a controlled fermentation process using fungal mycelium. The product is supplied as a semi-finished B2B ingredient to food manufacturers for use in creating alternative protein products. The product portfolio includes various application categories such as meat replacements, vegan cheese products, hybrid meat-mycoprotein products, snacks, and protein-enriched foods. The manufacturing process involves sourcing local sugars and nutrients, fermenting them with proprietary fungal strains, and harvesting the mycelium structure for supply to B2B customers.

Product and service2 records
1Promyc® Mycoprotein Ingredient
CategoryAlternative protein ingredient
2Co-creation Services
CategoryProduct development services
Description

Custom product development services offered to food manufacturers to co-create vegan, hybrid, and protein-enriched food products using Promyc mycoprotein as the base ingredient.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
1Naplasol (VEOS Group)
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2026-04-08
Description

Following the acquisition of Mycorena, Naplasol now produces and markets Promyc mycoproteins as part of their product portfolio, with production at their facility in Belgium.

food.greyb.com
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-25
Description

Mycorena and Revo Foods received €1.5 million in joint funding to develop 3D-printed mycoprotein products, advancing alternative protein sources using innovative manufacturing techniques.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-03-02
Description

Mycorena partnered with ICA Group (Swedish food retail company) to launch mycoprotein nuggets using the Promyc ingredient. This was a key B2B partnership for commercializing vegan meat alternatives in the Nordic market.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Fermentation-derived animal-free protein producer (formerly Clara Foods/EVERY) targeting egg and dairy protein replacements. Comparable as a precision/ biomass fermentation B2B ingredient peer to alternative protein manufacturers.

TypeEmerging player
Description

Austrian 3D-printed alt-protein company that co-developed mycoprotein products with Mycorena under a €1.5M grant. Adjacent peer leveraging similar fermentation-derived inputs for finished alt-protein foods.

TypeDirect peer
Description

US-based fermentation company producing a fungal protein (Fy) using a proprietary microbial platform. Comparable to Mycorena in core technology (fungal biomass fermentation) and B2B/consumer protein applications.

TypeDirect peer
Description

Category-defining mycoprotein producer with deep fermentation IP and broad retail presence. Quorn is the most direct competitor to Promyc in fungal mycoprotein, competing both at ingredient and finished-product levels.

TypeBroad incumbent
Description

Large alt-protein brand selling finished plant-based products through retail and foodservice. Less direct on technology (not mycoprotein) but a benchmark for category demand dynamics and B2B/partnership economics.

TypeEmerging player
Description

Precision fermentation dairy protein producer supplying B2B ingredients to food manufacturers. Comparable as a fermentation-based protein ingredient supplier using a different substrate (dairy proteins vs mycoprotein).

TypeBroad incumbent
Description

Established precision fermentation dairy protein company with global B2B distribution. Broader incumbent in the fermentation-protein ingredient space, useful as a comparable for scale, partnerships, and B2B GTM benchmarks.

TypeDirect peer
Description

Producer of mycoprotein (Abunda) via fungal fermentation, supplying food manufacturers as a B2B protein ingredient. Directly comparable to Promyc in mycoprotein ingredient model and target customers.

TypeBroad incumbent
Description

Major plant-based meat brand with global retail presence. Adjacent incumbent relevant for category-level demand signals and B2B foodservice supply economics relevant to Promyc's hybrid applications.

TypeEmerging player
Description

B2B supplier of plant-based protein ingredients (including via biomass/fermentation-adjacent processes) for hybrid and plant-based meat products. Comparable B2B ingredient strategy serving food manufacturers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mycorena

Alternative Protein Ingredientsmycorena.com

Mycorena developed Promyc, a mycelium-based fermented mycoprotein ingredient, supplying European food manufacturers via a B2B co-creation model for vegan meat, cheese, and hybrid products. Founded in Sweden in 2017, the company filed for bankruptcy and was acquired by Naplasol (VEOS Group) in August 2024.

What Mycorena does

Mycorena was a Swedish biotech startup founded in 2017 that developed Promyc, a 100% natural fermented mycoprotein ingredient produced from fungal mycelium through a proprietary fermentation process. The company's core technology combined locally sourced sugars and nutrients with proprietary fungal strains in a high-growth-rate fermentation process, yielding a mycelium root-like structure marketed as having neutral taste, strong nutritional value, and functional structuring properties suitable for meat alternatives, vegan cheese, hybrid meat-mycoprotein products, snacks, and protein-enriched foods. Mycorena operated as a B2B ingredient supplier targeting food manufacturers, offering co-creation services and semi-finished Promyc product, with distribution primarily in Europe and a notable partnership with Swedish retailer ICA Group for mycoprotein nuggets.

Mycorena raised approximately €24 million in a March 2022 Series A — described at the time as Europe's largest Series A for a Nordic alternative protein company — alongside a €1.5 million joint grant with Revo Foods in January 2023 for 3D-printed mycoprotein development. Despite these capital raises, the company encountered financial difficulties when further funding attempts failed and large-scale projects were discontinued, leading to a bankruptcy filing. In August 2024, Naplasol, a member of Belgium-based VEOS Group, acquired Mycorena, assuming ownership of the Promyc brand and mycoprotein technology. Since the acquisition, Promyc has been produced at Naplasol's facility in Bree, Belgium (Kanaal-Noord 1424), with an expanded applications portfolio marketed through a dedicated B2B co-creation channel targeting enterprise food manufacturers. Mycorena no longer operates as an independent entity; the Promyc platform is now a product line within Naplasol/VEOS Group.

Mycorena firmographics

Firmographics
Name
Mycorena
Legal name
Mycorena AB
Website
https://mycorena.com
Company type
Private
Founded year
2017
Operating status
Acquired
Headcount range
11–50 employees
Short description
Mycorena developed Promyc, a mycelium-based fermented mycoprotein ingredient, supplying European food manufacturers via a B2B co-creation model for vegan meat, cheese, and hybrid products. Founded in Sweden in 2017, the company filed for bankruptcy and was acquired by Naplasol (VEOS Group) in August 2024.
Ownership category
akta.pro rank

Mycorena industry classification

Industry
Product category
Alternative Protein Ingredients
NAICS
Food Manufacturing (311)
SIC
Miscellaneous Food Preparations & Kindred Products (2090), Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAJAHAE
Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
SECONDARYAFAKAGAG
Mycoprotein-Based Foods Manufacturing
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing

Keywords

  • Mycoprotein ingredients
  • Fungal fermentation technology
  • Plant-based protein ingredients
  • B2B food ingredients
  • Alternative protein supply

Where Mycorena is headquartered

Location

Headquarters

HQ city
Bree
HQ country
Belgium
HQ region
Europe

Offices1 record

Markets served

Mycorena business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Infrastructure, Marketing or Sales

Revenue model

  1. B2B Mycoprotein Ingredient Sales: Naplasol (now owning Mycorena's Promyc) operates as an industrial B2B supplier selling mycoprotein ingredients to food manufacturers for use in vegan and hybrid food products.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Mycorena product offering

Product offering

Core offering

Mycorena develops and supplies Promyc®, a 100% natural fermented mycoprotein ingredient produced from fungal mycelium through controlled fermentation. The ingredient is sold as a semi-finished B2B product to food manufacturers, who use it to develop vegan meat alternatives, vegan cheeses, hybrid meat-mycoprotein products, and other protein-enriched foods. Co-creation services support customers in formulating commercial products using Promyc.

Product overview

Mycorena, now owned by Naplasol (a member of VEOS Group), offers Promyc® as its core mycoprotein ingredient. Promyc® is a 100% natural, fermented mycoprotein produced through a controlled fermentation process using fungal mycelium. The product is supplied as a semi-finished B2B ingredient to food manufacturers for use in creating alternative protein products. The product portfolio includes various application categories such as meat replacements, vegan cheese products, hybrid meat-mycoprotein products, snacks, and protein-enriched foods. The manufacturing process involves sourcing local sugars and nutrients, fermenting them with proprietary fungal strains, and harvesting the mycelium structure for supply to B2B customers.

Differentiator

Problem solved

Functional benefit

Brands

  • Promyc: Mycoprotein ingredient brand developed by Mycorena, now owned and produced by Naplasol. Used in vegan meat alternatives, hybrid products, cheese alternatives, and various food applications.

Products and services

  • Promyc® Mycoprotein Ingredient
  • Co-creation Services Custom product development services offered to food manufacturers to co-create vegan, hybrid, and protein-enriched food products using Promyc mycoprotein as the base ingredient.

Companies that use Mycorena

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Mycorena technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Mycorena partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Naplasol (VEOS Group)coreOEM/ Whitelabel/ Licensing Partner · 8 April 2026Following the acquisition of Mycorena, Naplasol now produces and markets Promyc mycoproteins as part of their product portfolio, with production at their facility in Belgium.
  • Revo FoodsminorStrategic or Co-development Partner · 25 January 2023Mycorena and Revo Foods received €1.5 million in joint funding to develop 3D-printed mycoprotein products, advancing alternative protein sources using innovative manufacturing techniques.
  • ICA GroupcoreStrategic or Co-development Partner · 2 March 2022Mycorena partnered with ICA Group (Swedish food retail company) to launch mycoprotein nuggets using the Promyc ingredient. This was a key B2B partnership for commercializing vegan meat alternatives in the Nordic market.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Mycorena competitors and assessment

Company assessment

Emerging players

  • The EVERY Company: Fermentation-derived animal-free protein producer (formerly Clara Foods/EVERY) targeting egg and dairy protein replacements. Comparable as a precision/ biomass fermentation B2B ingredient peer to alternative protein manufacturers.
  • Revo Foods: Austrian 3D-printed alt-protein company that co-developed mycoprotein products with Mycorena under a €1.5M grant. Adjacent peer leveraging similar fermentation-derived inputs for finished alt-protein foods.
  • Remilk: Precision fermentation dairy protein producer supplying B2B ingredients to food manufacturers. Comparable as a fermentation-based protein ingredient supplier using a different substrate (dairy proteins vs mycoprotein).
  • Better Meat Co: B2B supplier of plant-based protein ingredients (including via biomass/fermentation-adjacent processes) for hybrid and plant-based meat products. Comparable B2B ingredient strategy serving food manufacturers.

Direct peers

  • Nature's Fynd: US-based fermentation company producing a fungal protein (Fy) using a proprietary microbial platform. Comparable to Mycorena in core technology (fungal biomass fermentation) and B2B/consumer protein applications.
  • Quorn Foods: Category-defining mycoprotein producer with deep fermentation IP and broad retail presence. Quorn is the most direct competitor to Promyc in fungal mycoprotein, competing both at ingredient and finished-product levels.
  • Enough (formerly 3F BIO): Producer of mycoprotein (Abunda) via fungal fermentation, supplying food manufacturers as a B2B protein ingredient. Directly comparable to Promyc in mycoprotein ingredient model and target customers.

Broad incumbents

  • Impossible Foods: Large alt-protein brand selling finished plant-based products through retail and foodservice. Less direct on technology (not mycoprotein) but a benchmark for category demand dynamics and B2B/partnership economics.
  • Perfect Day: Established precision fermentation dairy protein company with global B2B distribution. Broader incumbent in the fermentation-protein ingredient space, useful as a comparable for scale, partnerships, and B2B GTM benchmarks.
  • Beyond Meat: Major plant-based meat brand with global retail presence. Adjacent incumbent relevant for category-level demand signals and B2B foodservice supply economics relevant to Promyc's hybrid applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Mycorena social profiles

Digital presence

Mycorena financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mycorena leadership team

Management profile

Number of profiles

Profiles1 record

Mycorena funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mycorena M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mycorena

What does Mycorena do?

Mycorena develops and supplies Promyc®, a 100% natural fermented mycoprotein ingredient produced from fungal mycelium through controlled fermentation. The ingredient is sold as a semi-finished B2B product to food manufacturers, who use it to develop vegan meat alternatives, vegan cheeses, hybrid meat-mycoprotein products, and other protein-enriched foods. Co-creation services support customers in formulating commercial products using Promyc.

Is Mycorena a public or private company?

Mycorena is a private company. It is classified as corporate owned and is currently acquired.

When was Mycorena founded?

Mycorena was founded in 2017. It employs 11 to 50 people.

Where is Mycorena based?

Mycorena is headquartered in Bree, Belgium, in the Europe region.

How does Mycorena make money?

One revenue line is on record: B2B Mycoprotein Ingredient Sales.

Who are Mycorena's main competitors?

Emerging players on record are The EVERY Company, Revo Foods, Remilk and Better Meat Co. Direct peers are Nature's Fynd, Quorn Foods and Enough (formerly 3F BIO). Broad incumbents are Impossible Foods, Perfect Day and Beyond Meat.

Does Mycorena have an API?

No public API is recorded for Mycorena.

What industry is Mycorena in?

Mycorena's product category is Alternative Protein Ingredients. Its primary akta.pro industry code is AFAJAHAE, Mycoprotein & Fungal Proteins (Fusarium/Mycelium-Based), with a secondary code of AFAKAGAG, Mycoprotein-Based Foods Manufacturing. Its NAICS code is 311 and its SIC code is 2090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
vegconomistResearchers Map Three-Phase Path to Move Microbial Protein Into the MainstreamResearchers published a framework in Nature Communications outlining a three-phase strategy to transition microbial proteins from niche products to mainstream food staples. The study identifies consumer neophobia, high production costs, and regulatory hurdles as the primary barriers preventing widespread adoption of fermentation-derived proteins. It cites specific industry examples such as Mycorena's scale-up challenges and Quorn's historical success in normalizing fungal mycoprotein.GreyBKey Innovations in Yogurt Texture, Flavor, and Nutritional ProfileThis report examines innovation trends in the yogurt industry, highlighting advancements in microbial fermentation, plant-based alternatives, and functional ingredients designed to address consumer demand for sustainable, nutritious, and better-tasting products. Key innovations include Re-Milk's yeast-derived fermentation method for plant-based dairy alternatives, Naplasol's acquisition of Mycorena for mycelium-based proteins, and Fonterra's development of heat-stable whey proteins for enhanced texture. The report also covers regulatory challenges companies may face, including novel food approvals, GMO regulations, and labeling compliance requirements across different markets.TracxnTop Companies in Alternative Protein Ingredients (Jul, 2025)The article presents a list of top startups in the alternative protein ingredients sector, highlighting companies such as Mycorena, Enifer, and Plantible Foods. It details their specific technologies, including fungi-based fermentation and duckweed cultivation, along with key financial metrics like funding amounts and investor information. The report also notes that several of these startups were founded by alumni from universities in Sweden, Finland, Singapore, Israel, and the United States.Tech.euNaplasol acquires Mycorena to boost the mycelium and alt-protein marketNaplasol, a VEOS group member, acquired Swedish mycoprotein company Mycorena to expand its mycoprotein portfolio. Mycorena, which raised €35 million in funding, filed for bankruptcy in June after failing to secure Series B funding. Naplasol plans to produce Mycorena's Promyc at its Bree, Belgium facility.BBCWhat will we eat on the Moon? The food is literally out of this worldNASA plans to send astronauts to the Moon via Artemis in two years, prompting development of space food. Companies like Solar Foods and Mycorena are working on protein from space waste and fungi, with the third phase of the Deep Space Food Challenge underway this summer.Tech.euIn the mycelium revolution fungi roots are shaping the future of sustainable industriesMycelium-based startups are developing sustainable alternatives in textiles, packaging, construction, and meat substitutes. Companies like ENOUGH, Mycorena, and Adamo Foods are raising funding and scaling production, with some targeting whole-cut meat alternatives. The article highlights the growing ecosystem of fungal-based products across industries.BenzingaFrom Lab To Sea: The Startups Landing Sustainable Fish On Your PlateMycorena and Revo Foods are partnering to develop sustainable, 3D-printed vegan seafood using Mycorena's fungi-based mycoprotein to address overfishing and reduce environmental impact. The collaboration aims to produce fish-like products with fewer carbon emissions and less freshwater usage than traditional fishing methods while reaching commercial scale in 2023.Plantbasedworldpulse2023’s Innovative Plant-Based Fats To WatchAn April 27, 2023 article reviews plant-based fat innovations needed to improve the taste, texture and mouthfeel of plant-based meats, noting coconut and palm oil limitations including health and deforestation concerns. It profiles companies including Quibiq, Shiru, Omni Foods, Nourish and Mycorena, citing patents, investment and product launches.ArcticstartupSwedish foodtech startup receives €1.5M EU funding for the new project with Austrian startupSwedish foodtech startup Mycorena and Austrian startup Revo Foods have secured €1.5M in EU funding to develop mycoprotein optimized for 3D printing. The collaborative project aims to commercialize whole-cut vegan seafood options by adapting mycoprotein's fibrous structure for additive manufacturing. This initiative supports the EU's 'From farm to table' sustainability goals and represents a first-of-its-kind effort in the alternative protein space.foodnavigator.comBlending meat and mycoprotein: New hybrid products prepare to enter European marketMycorena is developing hybrid meat and mycoprotein products with Nybergs Deli and ICA, aiming to reduce meat consumption while offering a meat-like experience. The first commercial products are expected to hit shelves in Q4 2023. The collaboration follows Mycorena's earlier mycoprotein ingredient Promyc launch in 2019.